Jack A. Kent
Jack A. Kent is Managing Director, Innovative Healthcare Products at Becker Consulting. Mr. Kent’s activities include analysis of complex regulatory challenges and regulatory strategy for innovative products, preparation of regulatory submissions, assistance with preclinical and clinical programs, assistance with unique FDA approval challenges, preparation for FDA meetings and Advisory Panels, postmarketing product stewardship including Risk Management Programs, Quality Systems and Compliance support and management, due diligence for investments and acquisitions, litigation support, critical review of scientific data and regulatory literature, and preparation of reports on health-related topics. He is also responsible for preparing a project plan, forming and managing the project team, managing the timeline and budget of the project, updating the client on a regular basis, and assuring the quality of final work products.
Mr. Kent previously conducted research at the University of Maryland School of Medicine in circadian rhythms. Specifically, he recorded extracellular neuronal firing patterns from mouse suprachiasmatic nucleus and conducted behavior studies. His work is published in PLoS ONE online peer-reviewed journal.
Mr. Kent holds a BSE in Bioengineering from the University of Pennsylvania.
Send email to jack.kent@becker-consult.com.
Mr. Kent previously conducted research at the University of Maryland School of Medicine in circadian rhythms. Specifically, he recorded extracellular neuronal firing patterns from mouse suprachiasmatic nucleus and conducted behavior studies. His work is published in PLoS ONE online peer-reviewed journal.
Mr. Kent holds a BSE in Bioengineering from the University of Pennsylvania.
Send email to jack.kent@becker-consult.com.